Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.
Cornell-led research linking poverty and disease – and a promising path out of both – faces an uncertain future as federal science funding comes under pressure.
As psychedelic drugs gain more support from the medical community as a potential treatment for severe depression, Cornell researchers are making crucial discoveries that explain how compounds such as psilocybin work on the brain.
Contributions unveiled tools for analyzing environmental and health interventions, matching images to architectural plans, and generating realistic 3D scenes with unprecedented efficiency.
Caring for a family member with dementia can feel like losing a loved one who is still alive, but a new study suggests that revisiting memories together through a simple digital tool can help ease that grief.
Scholars converged at Cornell to talk about lessons policymakers and elected officials could glean from their research into the COVID pandemic to help deal with the next public health emergency.
A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.